Short answer
Specific parts of the eye, particularly the cornea and sclera, can be donated and transplanted successfully. The whole eye as a complete organ cannot currently be transplanted because the optic nerve cannot be reconnected.
Body & Brain
Every year, tens of thousands of people have their sight restored by donated tissue from someone who died. But in almost every case, the donated tissue is not what most people picture when they think of donating an eye. The whole eye cannot currently be transplanted. But specific layers of the eye can be, and the precision of modern corneal transplantation is something quite extraordinary. Imagine being able to repair a fogged lens on a camera without replacing the camera body. Modern eye donation is closer to precision optical component replacement than the wholesale organ transplant most people imagine.
Specific parts of the eye, particularly the cornea and sclera, can be donated and transplanted successfully. The whole eye as a complete organ cannot currently be transplanted because the optic nerve cannot be reconnected. Eye banks retrieve eyes from donors within hours of death, evaluate the tissue quality, and process specific layers for transplantation. The cornea, the clear front surface of the eye, is the most commonly transplanted part and restores sight in thousands of patients annually. Modern surgical techniques can transplant individual layers of the cornea rather than the full thickness, dramatically improving outcomes. The retina and optic nerve, which connect to the brain, remain outside current transplant capability.

Direct answer
Specific parts of the eye, particularly the cornea and sclera, can be donated and transplanted successfully. The whole eye as a complete organ cannot currently be transplanted because the optic nerve cannot be reconnected.
Eye banks retrieve eyes from donors within hours of death, evaluate the tissue quality, and process specific layers for transplantation. The cornea, the clear front surface of the eye, is the most commonly transplanted part and restores sight in thousands of patients annually. Modern surgical techniques can transplant individual layers of the cornea rather than the full thickness, dramatically improving outcomes. The retina and optic nerve, which connect to the brain, remain outside current transplant capability.
Short answer
Specific parts of the eye, particularly the cornea and sclera, can be donated and transplanted successfully. The whole eye as a complete organ cannot currently be transplanted because the optic nerve cannot be reconnected.
The curiosity gap
The whole eye cannot currently be transplanted. But specific layers of the eye can be, and the precision of modern corneal transplantation is something quite extraordinary.
Why it matters
The cornea, a transparent disc of tissue roughly the size of a shirt button, has no blood vessels and is immunologically privileged, meaning the body is far less likely to reject it than almost any other transplanted tissue. This quirk of anatomy has made corneal donation one of the most successful and routine forms of tissue transplantation in medicine.
Common misconception
You cannot donate your eyes for someone to receive a complete functional eye transplant. What you donate are specific tissues, most commonly the cornea.
The optic nerve, which connects the retina to the brain, cannot currently be reconnected after severance. The retina processes visual information and transmits it as electrical signals through the optic nerve to the visual cortex. Cutting and reattaching the optic nerve destroys the connection irreversibly. Without optic nerve reconnection, a transplanted eye would be anatomically present but functionally blind.
The same neural reconnection problem that prevents brain transplantation also prevents whole-eye transplantation, just with a smaller but still unresolvable number of nerve fibers.
DMEK (Descemet Membrane Endothelial Keratoplasty) is a technique that transplants only the innermost cellular layer of the cornea, approximately 10 to 15 microns thick, from a donor. It replaces only the diseased endothelial cells rather than the full corneal thickness. The technique produces dramatically faster visual recovery, much lower rejection rates, and better final visual acuity than previous full-thickness transplants.
Modern corneal transplantation has become so precise that surgeons are transplanting tissue layers thinner than a human hair with reliable success.
Research into bioengineered corneas is active and producing promising results. Lab-grown corneal endothelial cells have been transplanted successfully in small clinical trials. Collagen-based scaffolds seeded with corneal cells have been tested in humans in some countries. A fully functional synthetic cornea that matches donor tissue in all properties does not yet exist but is an active research goal given the worldwide shortage of donor corneas.
There are 12 million people worldwide waiting for a corneal transplant with no available donor. A bioengineered solution would be one of the most impactful interventions in global ophthalmology.
Visual answer
Eye donation works because transplant medicine uses specific eye tissues, especially the cornea, rather than replacing the whole eye. The optic nerve still cannot be reconnected, but corneal layers can be recovered, preserved, matched to the recipient's disease, and transplanted with high success.
Donation begins with careful tissue screening, not whole-eye replacement.
Most modern corneal donation is targeted layer repair.
Sight is restored by repairing the eye's clear optical surface.
Mechanism
Eye donation works because transplant medicine uses specific eye tissues, especially the cornea, rather than replacing the whole eye. The optic nerve still cannot be reconnected, but corneal layers can be recovered, preserved, matched to the recipient's disease, and transplanted with high success.
After death, an eye bank retrieves and evaluates the donated eye tissue under sterile conditions, checking corneal clarity, cell density, safety, and suitability for transplant.
It is like inspecting an optical lens before deciding whether it can be used in a precision repair.
Donation begins with careful tissue screening, not whole-eye replacement.
Depending on the recipient's condition, technicians may prepare a full-thickness corneal graft or only a thin endothelial layer such as DMEK tissue.
Modern corneal surgery can replace one damaged pane in a layered window instead of replacing the whole window.
Most modern corneal donation is targeted layer repair.
The surgeon removes the diseased corneal tissue and positions the donor tissue so light can again pass cleanly through the front of the eye.
The repair is closer to changing a camera lens element than transplanting an entire camera.
Sight is restored by repairing the eye's clear optical surface.
Evidence
Eduard Zirm, an Austrian ophthalmologist, performed the first successful human corneal transplant in 1905, taking a cornea from an 11-year-old boy whose eye had been removed due to injury and transplanting it into a farm laborer who had been blinded by chemical burns.
The patient recovered useful vision and retained it for years. Zirm's operation, which preceded the discovery of blood groups and the development of anti-rejection drugs by decades, succeeded because the cornea's lack of blood vessels meant the immune system never launched the full rejection response that would have destroyed any other transplanted tissue. The first successful organ or tissue transplant in human history succeeded partly because the surgeon, perhaps without fully understanding why, chose the one tissue in the body that the immune system was least likely to attack.
The Eye Bank for Sight Restoration was established in New York City in 1944, creating the infrastructure to collect, store, and distribute donor eye tissue systematically for the first time.
Before organized eye banking, corneal transplants were ad-hoc procedures requiring a conveniently timed donor. The eye bank model transformed them into scheduled, reproducible surgery and established the template for all subsequent tissue banking.
Dutch ophthalmologist Gerrit Melles developed the technique of transplanting only the Descemet membrane and endothelial layer of the cornea, a mere 10 to 15 microns of tissue, rather than full-thickness corneal buttons.
Patients achieved better final visual acuity, recovered faster, and had significantly lower rejection rates than with previous techniques. DMEK is now the preferred approach for endothelial diseases like Fuchs' dystrophy in most major centers worldwide.
The body part with the most nerve endings per square millimeter is also the one most likely to be successfully transplanted without rejection.
Corneal donation is one of the simplest and most impactful things a person can do, and the shortage is driven primarily by low awareness rather than medical limitations.
Evolution made the cornea transparent by removing its blood supply, and in doing so, accidentally made it the most transplant-friendly tissue in the body. Biology's optical solution became surgery's ethical windfall.
The properties most useful for one purpose sometimes create unexpected advantages in entirely different contexts.
Myths and edge cases
Myth
Eye banks remove the cornea or the entire eye under sterile conditions and can restore the donor's appearance with prosthetic shells before the funeral. The process is not visible at a viewing.
Standard eye donation protocols specifically address cosmetic concerns to maintain the option of open-casket funerals.
Myth
This is the most common misconception that discourages registration. Eye banks are completely separate from emergency and critical care medicine. The decision to declare death and the decision to request donation are handled by different teams under strict protocols.
Legal and hospital protocols in all countries with organized donation systems require that the care team and the donation team operate independently.
Edge case
Keratoconus is a condition where the central cornea thins and bulges forward into a cone shape, severely distorting vision. It affects roughly 1 in 2,000 people, often developing in the teenage years. In severe cases, corneal transplantation is the only treatment. These younger patients often receive full-thickness or anterior lamellar transplants because they need structural replacement, not just endothelial cell restoration.
Keratoconus makes corneal transplantation necessary in otherwise healthy young people, and the long-term success of their transplants is a testament to the cornea's immunological privilege.
Real world
Countries with opt-out donation systems, where citizens are presumed to consent unless they actively withdraw, have significantly higher donation rates and shorter waiting lists than opt-in systems.
Remember this
Parts of the eye, especially the cornea, can be donated and routinely restore sight.
The whole eye cannot be transplanted because the optic nerve cannot be reconnected.
The cornea's lack of blood vessels makes it uniquely resistant to immune rejection.
A single donor can help restore or improve the sight of up to five people.
Global demand for corneal transplants exceeds supply 70 to 1, primarily due to low donor registration.
Final thought
The cornea evolved to be clear. To be clear, it gave up its blood vessels. And in giving up those vessels, it became the most generous tissue in the body: replaceable, shareable, capable of being passed from the dead to the living with a precision and a success rate that no other organ has matched. Evolution designed an optical surface. It inadvertently designed a gift.
Quick answers
The optic nerve, which connects the retina to the brain, cannot currently be reconnected after severance. The retina processes visual information and transmits it as electrical signals through the optic nerve to the visual cortex. Cutting and reattaching the optic nerve destroys the connection irreversibly. Without optic nerve reconnection, a transplanted eye would be anatomically present but functionally blind.
DMEK (Descemet Membrane Endothelial Keratoplasty) is a technique that transplants only the innermost cellular layer of the cornea, approximately 10 to 15 microns thick, from a donor. It replaces only the diseased endothelial cells rather than the full corneal thickness. The technique produces dramatically faster visual recovery, much lower rejection rates, and better final visual acuity than previous full-thickness transplants.
Research into bioengineered corneas is active and producing promising results. Lab-grown corneal endothelial cells have been transplanted successfully in small clinical trials. Collagen-based scaffolds seeded with corneal cells have been tested in humans in some countries. A fully functional synthetic cornea that matches donor tissue in all properties does not yet exist but is an active research goal given the worldwide shortage of donor corneas.

